Stay updated on RP-A601 in PKP2-ACM Clinical Trial

Sign up to get notified when there's something new on the RP-A601 in PKP2-ACM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RP-A601 in PKP2-ACM Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the number of high-risk adult patients with PKP2-ACM enrolled in the Phase 1 dose escalation trial of RP-A601 for Arrhythmogenic Cardiomyopathy.
    Difference
    0.2%
    Check dated 2024-06-06T14:49:20.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study. Key inclusion criteria now specify age, consent capability, clinical diagnosis, genetic variant documentation, antibody assay results, and ICD implantation history.
    Difference
    16%
    Check dated 2024-05-22T21:26:25.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:18:12.000Z thumbnail image

Stay in the know with updates to RP-A601 in PKP2-ACM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RP-A601 in PKP2-ACM Clinical Trial page.